General Information of the Compound
Compound ID |
CP0088840
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-Cyano-N-(2,5-diphenyl-2H-pyrazol-3-yl)-benzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
3-Cyano-N-1,3-diphenyl-1H-pyrazol-5-yl)benzamide
3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
3-cyano-N-[2,5-di(phenyl)pyrazol-3-yl]benzamide
781652-57-1
A9858
AKOS024457497
B7324
BDBM50156071
CDPPB
CHEMBL190270
CTK5E5464
DB-075421
DTXSID80459996
EN002594
FT-0763465
GTPL1422
IN1239
KB-75992
MolPort-009-199-287
NCGC00370800-01
RTC-070344
SCHEMBL1823352
TC-070344
ZINC3986698
mGluR5 Ligand, CDPPB
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C23H16N4O
|
||||||||||||||||||
Molecular Weight |
364.408
|
||||||||||||||||||
Canonical SMILES |
O=C(Nc1cc(nn1-c1ccccc1)-c1ccccc1)c1cccc(c1)C#N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C23H16N4O/c24-16-17-8-7-11-19(14-17)23(28)25-22-15-21(18-9-3-1-4-10-18)26-27(22)20-12-5-2-6-13-20/h1-15H,(H,25,28)
Show/Hide
|
||||||||||||||||||
InChIKey |
BKUIZWILNWHFHD-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide )
Drug Name | 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | ||
---|---|---|---|
Target(s) |
Metabotropic glutamate receptor 5 (mGluR5)
Inhibitor
|